This is a working overview of nasal drops, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-25. Anything still debated is marked as such rather than presented as settled.
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
Circulation time for the peptide is short because peptidases cleave it readily. The Pro-Gly-Pro tail is thought to slow breakdown compared with the bare ACTH fragment, but the gain appears modest. Absorption after intranasal dosing is limited, and only a fraction of a dose is expected to reach the central nervous system. Laboratory concentrations therefore sit well above levels achieved systemically, a gap that complicates translation from bench findings to clinical claims.
The mechanisms attributed to semax are inferred from animal and cell studies rather than traced to one confirmed target. The most frequently cited pathway involves increased expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal and cortical tissue. Some work points to engagement of melanocortin receptors, particularly MC4, which the parent ACTH fragment can activate. Effects on dopaminergic and serotonergic signalling have also been reported. No single account explains all observed results, and the relative weight of each pathway remains unsettled.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid from research suppliers |
| Solubility | Freely soluble in water | Also dissolves in aqueous buffers; solutions are used fresh |
| Typical storage temperature | -20 °C for lyophilized powder | Short-term transport at 2-8 °C is common |
| Common analytical method | Reverse-phase HPLC | Paired with mass spectrometry for identity confirmation |
| Common synonyms | ACTH(4-10) analogue; MEHFPGP | N-terminal methionine retained in the chain |
Routine characterization relies on reversed-phase high-performance liquid chromatography to establish purity and on mass spectrometry to confirm molecular identity. Electrospray ionization and matrix-assisted laser desorption ionization are both used for mass verification. Amino acid analysis and peptide mapping can detect sequence errors. Common impurities include truncated sequences, methionine sulfoxide formed by oxidation, and deamidated products. Chromatograms are usually recorded near 214 nm, where the peptide backbone absorbs, and purity is reported as the percentage area of the principal peak.
Verification of a supplied batch generally combines a certificate of analysis with independent testing, because certificates are self-reported documents. A typical package includes a chromatographic trace, a mass spectrum, and a stated water or counter-ion content. Batch-to-batch consistency matters more than a single purity figure when results are compared across experiments. No single mandatory standard governs research-grade peptide release, so laboratories are expected to define their own acceptance criteria. Residual trifluoroacetate from purification is a frequently overlooked counter-ion.
Lyophilized material is chemically stable for extended periods when kept dry, cold, and protected from light. The powder is hygroscopic, so vials should be warmed to room temperature before opening to reduce condensation on the contents. Once dissolved, the peptide is far less stable because peptide bonds are susceptible to hydrolysis and the methionine residue can oxidize. Solutions are typically aliquoted and held at 2-8 °C for short intervals or frozen for longer ones, and repeated freeze-thaw cycles should be avoided.
Semax 是人工设计的七肽，序列为 Met-Glu-His-Phe-Pro-Gly-Pro，骨架取自促肾上腺皮质激素片段 ACTH(4-10)。它于二十世纪八十年代在苏联的分子遗传学研究机构内合成。设计目标是保留该片段与注意力和记忆相关的活性，同时剔除促皮质激素释放等内分泌作用。此后俄罗斯将其登记为药品并进入临床使用。
当时的短肽研究普遍关注能否穿越血脑屏障、在低剂量下产生中枢效应，Semax 属于这一路线。鼻内给药是其主要使用方式，俄语文献报道的适应症涵盖缺血性卒中、短暂性脑缺血发作、认知功能减退以及视神经病变。这些研究大多发表在当地期刊上，样本规模与终点设置同西方试验惯例存在差异，国际同行对其临床证据的强度看法不一。
各国监管态度分化明显。俄罗斯按处方药管理，部分东欧国家留有使用记录；欧盟与美国未批准其作为药物上市，市面流通品通常标注为研究用化学品。身份差异意味着标示含量、纯度与无菌性缺少统一核查。体育领域还牵涉反兴奋剂名录，跨境携带则受目的地药品法规约束。
溶液状态的稳定性明显低于冻干粉。肽类在水溶液中可能经历水解、氧化与聚集，其中甲硫氨酸和天冬酰胺等残基常是敏感位点。Semax 含有甲硫氨酸，因此氧化风险相对突出。工作液一般主张现配现用，或冷藏并在数日内用尽。缓冲液种类、pH 和离子强度都会影响降解速率，而关于最佳条件的公开数据并不统一。
常规纯度与身份确认依赖反相高效液相色谱，并辅以质谱测定分子量。氨基酸组成分析可用于验证序列构成，肽图分析则能进一步定位修饰或降解产物。杂质谱通常关注缺失序列肽、截短片段和氧化产物。不同方法的检出限并不相同，因此各实验室报告的纯度数值不宜直接横向比较。
多数实验室与市售的 Semax 以冻干粉形式提供。冻干粉通常建议保存在 -20 °C 或更低温度下，同时避免光照与反复升温。短期运输有时采用冷藏条件，但长期保存仍以冷冻为主。分包操作应尽量减少开盖次数，以降低吸湿和微生物污染的风险。开封后若未一次用完，建议在干燥环境中密封并尽快放回低温储存。
Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.
The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.
Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.
Emerging evidence suggests that the gut microbiome may also provide predictive information for response to immune checkpoint blockade. In a multi-regional study 674 patients with resected high-risk melanoma receiving adjuvant immune checkpoint blockade, pre-treatment gut bacterial markers were associated with recurrence, with prediction performing best when patients were compared within groups matched for overall gut microbiome composition, suggesting that microbiome-based biomarkers may be informative but context dependent. PD-1 and PD-L1 inhibitors are closely related to CTLA4 (cytotoxic T-lymphocyte-associated protein 4) inhibitors, such as ipilimumab. PD-1 and CTLA-4 are both expressed on activated T cells, but at different phases of immune response. Current clinical trials are evaluating anti-PD-1 and PD-L1 drugs in combination with other immunotherapy drugs blocking LAG3, B7-H3, KIR, OX40, PARP, CD27, and ICOS.
The fifth season had twelve roles receiving star billing, with eleven of them returning from the previous season, eight of which part of the original cast from the first season, and three new cast members being added. Kerry Washington continued to play her role as protagonist of the series, Olivia Pope, a former White House Director of Communications with her own crisis management firm. Darby Stanchfield played Abby Whelan, the White House Press Secretary, Katie Lowes portrayed Quinn Perkins, and Guillermo Diaz portrayed Huck, the troubled tech guy who works for Olivia. Cornelius Smith Jr. continued his role as activist Marcus Walker. after being upgraded to series regular. Jeff Perry continued to portray Cyrus Beene, chief of staff at the White House who was fired by Fitz but later rehired. Portia de Rossi played Elizabeth North, the new chief of staff at the White House, and later the chief of staff for the vice president. Joshua Malina played the role of David Rosen, former U.S. Attorney, now Attorney General. Bellamy Young continued to act as First Lady/Senator Melody "Mellie" Grant, who was kicked out of the White House by Fitz, and later joined the presidential campaign for president. Tony Goldwyn continued to portray President Fitzgerald "Fitz" Thomas Grant III. Scott Foley portrayed Jake Ballard a former B613 agent and later the head of the NSA. On May 14, 2015, after the fourth-season finale, it was announced that Portia de Rossi had been promoted to a series regular for the fifth season.
According to the 2011 census, the literacy rate in Jammu and Kashmir was 67.17%, male literacy was 75%, while female literacy was at 56.43%. University of Kashmir located in Srinagar is the main university in the territory. Other universities include University of Jammu, Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir, Shri Mata Vaishno Devi University, Islamic University of Science & Technology, etc. Major institutions of higher education are NIT Srinagar, IIT Jammu, IIM Jammu, NIFT Srinagar and IHM Srinagar. Medical colleges include SKIMS, and the Government Medical College in Srinagar and All India Institute of Medical Sciences, Vijaypur, Jammu.
Sources: en.wikipedia.org
Staley met guitarist Jerry Cantrell at a party in Seattle while working at Music Bank rehearsal studios in 1987. A few months before that, Cantrell had watched Staley performing with his then-band, Alice N' Chains, in his hometown at the Tacoma Little Theatre, and was impressed by his voice. Cantrell was homeless after being kicked out of his family's house, so Staley invited Cantrell to live with him at the Music Bank. The two fast friends lived as roommates for over a year in the dilapidated rehearsal space they shared. Alice N' Chains soon disbanded and Staley joined a funk band, which at the time also required a guitarist. He asked Cantrell to join as a sideman. Cantrell agreed on condition that Staley join his band, which at the time did not have a name and included drummer Sean Kinney and bassist Mike Starr. They started auditioning terrible lead singers in front of Staley to send a hint, which made him angry. The final straw for Staley was when they auditioned a male stripper in front of him – he decided to join the band after that. Cantrell said this about Staley's voice: "I knew that voice was the guy I wanted to be playing with. It sounded like it came out of a 350-pound biker rather than skinny little Layne. I considered his voice to be my voice." Eventually the funk project broke up, and in 1987, Staley joined Cantrell's band on a full-time basis. The band had names like "Fuck" and "Diamond Lie", the latter being the name of Cantrell's previous band.
== Tourism == The World Economic Forum's Travel & Tourism Competitiveness Index 2017 Report, ranked Thailand 34 of 136 nations (1=most competitive, 136=least competitive). Other ASEAN nations ranked were: Singapore, 6; Malaysia, 26; Indonesia, 42; Vietnam, 67; Philippines, 79; Laos, 94; Cambodia, 101. International Tourist Arrivals and Receipts: Thailand ranked number nine in 2016, with 32.5 million arrivals. It ranked third in international tourism receipts, US$49.9 billion. Global Destinations Cities Index 2016: In this seventh annual survey published by MasterCard, Bangkok ranked number one of 100 cities worldwide as the top global destination city as determined by number of visitors. It displaced London, the previous number one. Other ASEAN cities ranked in the survey were Singapore, 6; Ho Chi Minh City, 42; Hanoi, 52; Jakarta, 66; and Manila, 74. Travel and Tourism Competitiveness Report 2015: Thailand ranked 35 of 141 nations. Among ASEAN nations, Singapore was ranked 11; Malaysia, 25: Indonesia, 50; Philippines, 74; Vietnam, 75; Laos, 96; Cambodia, 105; and Myanmar, 134. International Tourist Arrivals: Thailand ranked number ten in 2013, up five places from 2012 with 26.5 million arrivals. International Tourist Receipts: Ranked number seven in the world in 2013, up two places from 2012, with receipts estimated at US$42.1 billion. Total tourism contribution to GDP: Thailand ranked 18 of 184 nations in 2014, with travel and tourism income totalling 2,345 billion baht or 19.3 percent of GDP.
=== Parthenogenesis === When female American cockroaches are housed in groups, this close association promotes facultative parthenogenic reproduction. The oothecae are produced asexually, without fertilization. The process by which the eggs are produced is automixis; during automixis, meiosis occurs, but instead of giving rise to haploid gametes as ordinarily happens, diploid gametes are produced (probably by terminal fusion of meiotic products) that can then develop into female cockroaches. Eggs produced by parthenogenesis have lower viability than eggs produced by sexual reproduction.
Di Prisco G, Casola L, Giuditta A (1967). "Purification and properties of a soluble reduced nicotinamide-adenine dinucleotide (phosphate) dehydrogenase from the hepatopancreas of Octopus vulgaris". Biochem. J. 105 (2): 455–60. doi:10.1042/bj1050455. PMC 1198331. PMID 4171422. GIUDITTA A, STRECKER HJ (1961). "Purification and some properties of a brain diaphorase". Biochim. Biophys. Acta. 48: 10–9. doi:10.1016/0006-3002(61)90509-1. PMID 13705804. MAERKI F, MARTIUS C (1960). "[Vitamin K reductase, preparation and properties.]". Biochem. Z. 333: 111–35. PMID 13765127. Misaka E, Nakanishi K. "Studies on menadione reductase of bakers' yeast. I. Purification, crystallization and some properties". J. Biochem. Tokyo: 465–471. WOSILAIT WD (1960). "The reduction of vitamin K1 by an enzyme from dog liver". J. Biol. Chem. 235 (4): 1196–201. doi:10.1016/S0021-9258(18)69504-3. PMID 13846011. Sparla F, Tedeschi G, Trost P (1996). "NAD(P)H:(Quinone-Acceptor) Oxidoreductase of Tobacco Leaves Is a Flavin Mononucleotide-Containing Flavoenzyme". Plant Physiol. 112 (1): 249–258. doi:10.1104/pp.112.1.249. PMC 157943. PMID 12226388. Braun M, Bungert S, Friedrich T (1998). "Characterization of the overproduced NADH dehydrogenase fragment of the NADH:ubiquinone oxidoreductase (complex I) from Escherichia coli". Biochemistry. 37 (7): 1861–7. doi:10.1021/bi971176p. PMID 9485311. Jaiswal AK (2000). "Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases". Arch. Biochem. Biophys. 375 (1): 62–8. doi:10.1006/abbi.1999.1650. PMID 10683249.
Sources: en.wikipedia.org
My job duties require I wear the designated Hooters Girl uniform. My job duties require that I interact with and entertain the customers. The Hooters concept is based on female sex appeal and the work environment is one in which joking and entertaining conversations are commonplace.
== Metabolism == Metabolism of this compound has been assessed, revealing diclazepam has an approximate elimination half-life of 42 hours and undergoes N-demethylation to delorazepam, which can be detected in urine for 6 days following administration of the parent compound. Other metabolites detected were lorazepam and lormetazepam which were detectable in urine for 19 and 11 days, respectively, indicating hydroxylation by cytochrome P450 enzymes occurring concurrently with N-demethylation.
129I beta-decays to 129Xe with a half-life of 16.14±0.12 million years. The iodine-xenon chronometer is an isochron technique. Samples are exposed to neutrons in a nuclear reactor. This converts the only stable isotope of iodine (127I) into 128Xe via neutron capture followed by beta decay (of 128I). After irradiation, samples are heated in a series of steps and the xenon isotopic signature of the gas evolved in each step is analysed. When a consistent 129Xe/128Xe ratio is observed across several consecutive temperature steps, it can be interpreted as corresponding to a time at which the sample stopped losing xenon. Samples of a meteorite called Shallowater are usually included in the irradiation to monitor the conversion efficiency from 127I to 128Xe. The difference between the measured 129Xe/128Xe ratios of the sample and Shallowater then corresponds to the different ratios of 129I/127I when they each stopped losing xenon. This in turn corresponds to a difference in age of closure in the early solar system.
Sources: en.wikipedia.org
It consists mainly of animal experiments and small clinical reports, with much of the clinical material published in Russian-language journals. Large independent trials are scarce. Separating reliable effects from chance findings is consequently difficult.
A fraction of an intranasal dose is thought to reach the central nervous system, and this route is favoured partly for that reason. The proportion is not well characterized. Direct measurement in humans remains difficult with current methods.
Raised BDNF and NGF expression has been reported across several animal studies, which makes the signal fairly consistent. Whether the same change occurs in humans at usable doses is not established. It is best treated as a working hypothesis rather than a confirmed clinical mechanism.
It is a synthetic seven-amino-acid peptide built from the ACTH(4-7) sequence plus a Pro-Gly-Pro tail. It belongs to the family of short ACTH fragments studied for nervous-system effects. Its backbone contains only standard amino acids.